Resveratrol

Resveratrol is a naturally occurring polyphenol found in red wine, grapes, blueberries, and peanuts that has attracted significant scientific attention, particularly around its potential effects on metabolic health, longevity pathways, cardiovascular function, and age-related diseases. The available evidence base includes a mix of narrative reviews, a small number of randomized controlled trials (RCTs), and meta-analyses, but the overall picture remains far from definitive. Of the 78 expert claims evaluated against this literature, only 1 was fully supported and 10 were partially supported, with 67 rated as having insufficient evidence — a striking signal that enthusiasm for resveratrol has substantially outpaced the human clinical data. Among the more credible findings, one moderate-quality RCT examined resveratrol supplementation in patients with type 2 diabetes and reported improvements in markers of glucose regulation, inflammation, and oxidative stress, though the study size and duration limit how much can be concluded. Separate RCTs suggest potential benefits for bone mineral density in postmenopausal women, including improvements in bone turnover biomarkers when resveratrol was combined with equol. A strong-quality meta-analysis on dietary polyphenols (including resveratrol) in non-alcoholic fatty liver disease found some positive signals, and another strong meta-analysis on sleep supplements noted modest effects in its broader polyphenol analysis. Resveratrol's connection to sirtuin activation and longevity biology — popularized by David Sinclair's foundational research — is acknowledged across multiple reviews, though translating this mechanism into confirmed human health outcomes remains an open question. The most important caveat is that a substantial portion of resveratrol's proposed benefits rest on preclinical (animal and cell-based) data that has not been reliably replicated in rigorous human trials. The human RCTs that do exist are generally small, short-term, and conducted in specific populations (e.g., diabetic adults, postmenopausal women), making it premature to generalize findings to healthy adults or other groups. Key areas such as cancer chemoprevention, ophthalmic diseases, Alzheimer's disease, endometriosis, and preeclampsia are covered only by narrative reviews without supporting clinical trial data in this evidence set. Bioavailability is a known challenge with resveratrol — it is rapidly metabolized, raising questions about what doses actually reach target tissues. The optimal dose, formulation, and duration of supplementation remain undefined.

This is educational information only. Consult a healthcare provider before starting any supplement.